Brinker Capital Investments’s BeOne Medicines Ltd ONC Stock Holding History

Brinker Capital Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$832K	Buy	2,918 +41	+1%	+$12.1K	0.01%	1255
2026 Q1	$854K	Sell	2,877 -55	-2%	-$17.8K	0.01%	1202
2025 Q4	$891K	Buy	2,932 +117	+4%	+$38.3K	0.01%	1295
2025 Q3	$959K	Buy	2,815 +651	+30%	+$198K	0.01%	1255
2025 Q2	$524K	Buy	+2,164	New	+$531K	﹤0.01%	1487
2022 Q1	–	Sell	-4,048	Closed	-$1.1M	–	1420
2021 Q4	$1.1M	Sell	4,048 -136	-3%	-$45.9K	0.02%	785
2021 Q3	$1.44M	Hold	4,184	–	–	0.02%	644
2021 Q2	$1.44M	Buy	4,184 +454	+12%	+$150K	0.02%	702
2021 Q1	$1.3M	Sell	3,730 -4,054	-52%	-$1.34M	0.02%	625
2020 Q4	$2.01M	Buy	7,784 +3,709	+91%	+$1.02M	0.03%	556
2020 Q3	$1.17M	Buy	+4,075	New	+$958K	0.02%	639

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brinker Capital Investments's ONC Position: Q2 2026 in Review

Brinker Capital Investments increased its BeOne Medicines Ltd (ONC) stake by 1.4% in Q2 2026, buying an estimated $12.1K and bringing the position to 2,918 shares worth $832K. The position accounts for 0.01% of the portfolio, ranked #1255.

Brinker Capital Investments first reported a position in ONC in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.01M in Q4 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Brinker Capital Investments held 2,918 shares of BeOne Medicines Ltd worth $832K as of Q2 2026.
Brinker Capital Investments bought 41 BeOne Medicines Ltd shares in Q2 2026, an estimated $12.1K.
BeOne Medicines Ltd made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1255 holding.
Brinker Capital Investments first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 11 quarters since.
Brinker Capital Investments's BeOne Medicines Ltd position peaked at $2.01M in Q4 2020.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.